After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...

Crohn’s disease is a type of inflammatory bowel disease (IBD) that involves periods of remission and flares. Symptoms can ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

Complementary and alternative therapies for Crohn’s disease, like acupuncture and meditation, are useful approaches to managing symptoms in combination with a treatment plan.

Eli Lilly's Omvoh shows long-term efficacy against ulcerative colitis and Crohn's disease, with high rates of remission ...

Eli Lilly announced that mirikizumab achieved long-term remission in Phase 3 IBD studies, showing promise for ulcerative ...

A new study explores the role of dysfunctioning mitochondria and a disrupted gut microbiome as a possible trigger of Crohn's ...

Breastfeeding, child nutrition and exposure to secondhand tobacco smoke at an early age may play a role in the onset of ...

Children who are exclusively breastfed for the first six months may subsequently have a lower risk of suffering from Crohn 's disease, according to Montreal researchers.

US pharma major Eli Lilly has released results from two, multi-year, Phase III studies that showed patients treated with ...

A new study in mice suggests that dysfunctional mitochondria may change the gut microbiome and thus drive Crohn's disease.